{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T10:51:17Z","timestamp":1791629477741,"version":"4.3.4"},"publisher-location":"Berlin, Heidelberg","reference-count":162,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/82_2026_362","type":"book-chapter","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T10:39:02Z","timestamp":1791628742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Defective Inflammation Resolution in Cystic Fibrosis: Cellular Mechanisms and Emerging Pro-resolving Therapies in the CFTR Modulator Era"],"prefix":"10.1007","author":[{"given":"Mario","family":"Romano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"D\u2019Orazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Mattoscio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Mucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shameer","family":"Pillarisetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Recchiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,11]]},"reference":[{"issue":"6","key":"362_CR1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jcf.2018.03.010","volume":"17","author":"D Adam","year":"2018","unstructured":"Adam D, Bilodeau C, Sognigb\u00e9 L, Maill\u00e9 \u00c9, Ruffin M, Brochiero E (2018) CFTR rescue with VX-809 and VX-770 favors the repair of primary airway epithelial cell cultures from patients with class II mutations in the presence of Pseudomonas aeruginosa exoproducts. J Cyst Fibros 17(6):705\u2013714. https:\/\/doi.org\/10.1016\/j.jcf.2018.03.010","journal-title":"J Cyst Fibros"},{"issue":"8","key":"362_CR2","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.12093","volume":"2","author":"M Al-Alawi","year":"2014","unstructured":"Al-Alawi M, Buchanan P, Verriere V, Higgins G, McCabe O, Costello RW, McNally P, Urbach V, Harvey BJ (2014) Physiological levels of lipoxin A4 inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium. Physiol Rep 2(8):e12093. https:\/\/doi.org\/10.14814\/phy2.12093","journal-title":"Physiol Rep"},{"issue":"23","key":"362_CR3","doi-asserted-by":"publisher","first-page":"4750","DOI":"10.1111\/bph.17322","volume":"181","author":"PRJ Almeida","year":"2024","unstructured":"Almeida PRJ, Periard AM, Tana FL, Avila RE, Milhorato LB, Alcantara KMM, Resende CB, Serufo AV, Santos FR, Teixeira DC, Queiroz-Junior CM, Fonseca TCM, Silva BLV, Costa VV, Souza RP, Perretti M, Jonassen TEN, Teixeira MM (2024) Effects of a pro-resolving drug in COVID-19: preclinical studies to a randomized, placebo-controlled, phase Ib\/IIa trial in hospitalized patients. Br J Pharmacol 181(23):4750\u20134765. https:\/\/doi.org\/10.1111\/bph.17322","journal-title":"Br J Pharmacol"},{"issue":"8","key":"362_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13891","volume":"17","author":"P Badorrek","year":"2024","unstructured":"Badorrek P, Diefenbach C, K\u00f6gler H, Eleftheraki A, Seitz F, Hohlfeld JM (2024) Novel cathepsin C inhibitor, BI 1291583, intended for treatment of bronchiectasis: phase I characterization in healthy volunteers. Clin Transl Sci 17(8):e13891. https:\/\/doi.org\/10.1111\/cts.13891","journal-title":"Clin Transl Sci"},{"issue":"4","key":"362_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/adc.75.4.319","volume":"75","author":"IM Balfour-Lynn","year":"1996","unstructured":"Balfour-Lynn IM, Laverty A, Dinwiddie R (1996) Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 75(4):319\u2013322. https:\/\/doi.org\/10.1136\/adc.75.4.319","journal-title":"Arch Dis Child"},{"issue":"2","key":"362_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ppul.1950200203","volume":"20","author":"K Balough","year":"1995","unstructured":"Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R (1995) The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 20(2):63\u201370. https:\/\/doi.org\/10.1002\/ppul.1950200203","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"362_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri.2015.4","volume":"16","author":"MC Basil","year":"2016","unstructured":"Basil MC, Levy BD (2016) Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol 16(1):51\u201367. https:\/\/doi.org\/10.1038\/nri.2015.4","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"362_CR8","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1074\/mcp.M500019-MCP200","volume":"4","author":"N Bensalem","year":"2005","unstructured":"Bensalem N, Ventura AP, Vall\u00e9e B, Lipecka J, Tondelier D, Davezac N, Santos AD, Perretti M, Fajac A, Sermet-Gaudelus I, Renouil M, Lesure J-F, Halgand F, Lapr\u00e9vote O, Edelman A (2005) Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients. Mol Cell Proteomics 4(10):1591\u20131601. https:\/\/doi.org\/10.1074\/mcp.M500019-MCP200","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"362_CR9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2313089121","volume":"121","author":"M Briottet","year":"2024","unstructured":"Briottet M, Sy K, London C, Aissat A, Shum M, Escabasse V, Louis B, Urbach V (2024) Specialized proresolving mediator resolvin E1 corrects the altered cystic fibrosis nasal epithelium cilia beating dynamics. Proc Natl Acad Sci USA 121(5):e2313089121. https:\/\/doi.org\/10.1073\/pnas.2313089121","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"362_CR10","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.jcf.2025.08.002","volume":"24","author":"E Brunet-Ratnasingham","year":"2025","unstructured":"Brunet-Ratnasingham E, Tsao T, Mohanty RP, Arias-Soto O, Kapse B, Greenland JR, Calabrese DR (2025) Cystic fibrosis airway epithelial cells have an exaggerated response to hypoxia that is partially reversible through transmembrane receptor modulation. J Cyst Fibros 24(6):1156\u20131165. https:\/\/doi.org\/10.1016\/j.jcf.2025.08.002","journal-title":"J Cyst Fibros"},{"issue":"3","key":"362_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1165\/rcmb.2008-0170OC","volume":"40","author":"EM Bruscia","year":"2009","unstructured":"Bruscia EM, Zhang P-X, Ferreira E, Caputo C, Emerson JW, Tuck D, Krause DS, Egan ME (2009) Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator \u2212\/\u2212 mice. Am J Respir Cell Mol Biol 40(3):295\u2013304. https:\/\/doi.org\/10.1165\/rcmb.2008-0170OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"362_CR12","doi-asserted-by":"publisher","first-page":"L193","DOI":"10.1152\/ajplung.00058.2013","volume":"305","author":"PJ Buchanan","year":"2013","unstructured":"Buchanan PJ, McNally P, Harvey BJ, Urbach V (2013) Lipoxin A4-mediated KATP potassium channel activation results in cystic fibrosis airway epithelial repair. Am J Physiol Lung Cell Mol Physiol 305(2):L193\u2013L201. https:\/\/doi.org\/10.1152\/ajplung.00058.2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"362_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-26263-y","volume":"15","author":"A Cammarata-Mouchtouris","year":"2025","unstructured":"Cammarata-Mouchtouris A, Giraldo DM, Collins GL, Parrilla MM, Kim SO, Mansour S, Giacalone VD, Cottrill KA, Tirouvanziam R, Chandler JD (2025) People with cystic fibrosis with high sputum neutrophil elastase on elexacaftor-tezacaftor-ivacaftor exhibit worse pulmonary function and pro-inflammatory airway milieu. Sci Rep 15(1):43430. https:\/\/doi.org\/10.1038\/s41598-025-26263-y","journal-title":"Sci Rep"},{"issue":"4","key":"362_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jcf.2015.03.003","volume":"14","author":"AM Cantin","year":"2015","unstructured":"Cantin AM, Hartl D, Konstan MW, Chmiel JF (2015) Inflammation in cystic fibrosis lung disease: pathogenesis and therapy. J Cyst Fibros 14(4):419\u2013430. https:\/\/doi.org\/10.1016\/j.jcf.2015.03.003","journal-title":"J Cyst Fibros"},{"issue":"8","key":"362_CR15","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1164\/rccm.200203-179OC","volume":"167","author":"GE Carpagnano","year":"2003","unstructured":"Carpagnano GE, Barnes PJ, Geddes DM, Hodson ME, Kharitonov SA (2003) Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med 167(8):1109\u20131112. https:\/\/doi.org\/10.1164\/rccm.200203-179OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"362_CR16","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/s0046-8177(96)90011-8","volume":"21","author":"JL Carson","year":"1990","unstructured":"Carson JL, Collier AM, Gambling TM, Knowles MR, Boucher RC (1990) Ultrastructure of airway epithelial cell membranes among patients with cystic fibrosis. Hum Pathol 21(6):640\u2013647. https:\/\/doi.org\/10.1016\/s0046-8177(96)90011-8","journal-title":"Hum Pathol"},{"issue":"8","key":"362_CR17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1136\/thorax-2022-219943","volume":"78","author":"M Casey","year":"2023","unstructured":"Casey M, Gabillard-Lefort C, McElvaney OF, McElvaney OJ, Carroll T, Heeney RC, Gunaratnam C, Reeves EP, Murphy MP, McElvaney NG (2023) Effect of elexacaftor\/tezacaftor\/ivacaftor on airway and systemic inflammation in cystic fibrosis. Thorax 78(8):835\u2013839. https:\/\/doi.org\/10.1136\/thorax-2022-219943","journal-title":"Thorax"},{"issue":"5","key":"362_CR18","doi-asserted-by":"publisher","first-page":"445","DOI":"10.14670\/HH-11-842","volume":"32","author":"S Castellani","year":"2017","unstructured":"Castellani S, Favia M, Guerra L, Carbone A, Abbattiscianni AC, Di Gioia S, Casavola V, Conese M (2017) Emerging relationship between CFTR, actin and tight junction organization in cystic fibrosis airway epithelium. Histol Histopathol 32(5):445\u2013459. https:\/\/doi.org\/10.14670\/HH-11-842","journal-title":"Histol Histopathol"},{"issue":"23","key":"362_CR19","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15128","volume":"9","author":"AJ Causer","year":"2021","unstructured":"Causer AJ, Khalaf M, Klein Rot E, Brand K, Smith J, Bailey SJ, Cummings MH, Shepherd AI, Saynor ZL, Shute JK (2021) CFTR limits F-actin formation and promotes morphological alignment with flow in human lung microvascular endothelial cells. Physiol Rep 9(23):e15128. https:\/\/doi.org\/10.14814\/phy2.15128","journal-title":"Physiol Rep"},{"issue":"1","key":"362_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jcf.2020.09.008","volume":"20","author":"JF Chmiel","year":"2021","unstructured":"Chmiel JF, Flume P, Downey DG, Dozor AJ, Colombo C, Mazurek H, Sapiejka E, Rachel M, Constantine S, Conley B, Dgetluck N, Dinh Q, White B, Elborn JS (2021) Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis. J Cyst Fibros 20(1):78\u201385. https:\/\/doi.org\/10.1016\/j.jcf.2020.09.008","journal-title":"J Cyst Fibros"},{"issue":"4","key":"362_CR21","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1164\/ajrccm.162.4.9911071","volume":"162","author":"G Ciabattoni","year":"2000","unstructured":"Ciabattoni G, Dav\u00ec G, Collura M, Iapichino L, Pardo F, Ganci A, Romagnoli R, Maclouf J, Patrono C (2000) In vivo lipid peroxidation and platelet activation in cystic fibrosis. Am J Respir Crit Care Med 162(4):1195\u20131201. https:\/\/doi.org\/10.1164\/ajrccm.162.4.9911071","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"362_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/mi.2017.36","volume":"11","author":"M Codagnone","year":"2018","unstructured":"Codagnone M, Cianci E, Lamolinara A, Mari VC, Nespoli A, Isopi E, Mattoscio D, Arita M, Bragonzi A, Iezzi M, Romano M, Recchiuti A (2018) Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection. Mucosal Immunol 11(1):35\u201349. https:\/\/doi.org\/10.1038\/mi.2017.36","journal-title":"Mucosal Immunol"},{"issue":"6","key":"362_CR23","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/j.jcf.2021.09.019","volume":"20","author":"AM Collin","year":"2021","unstructured":"Collin AM, Lecocq M, Detry B, Carlier FM, Bouzin C, de Sany P, Hoton D, Verleden S, Froidure A, Pilette C, Gohy S (2021) Loss of ciliated cells and altered airway epithelial integrity in cystic fibrosis. J Cyst Fibros 20(6):e129\u2013e139. https:\/\/doi.org\/10.1016\/j.jcf.2021.09.019","journal-title":"J Cyst Fibros"},{"issue":"1","key":"362_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/pathophysiology28010011","volume":"28","author":"M Conese","year":"2021","unstructured":"Conese M, Di Gioia S (2021) Pathophysiology of lung disease and wound repair in cystic fibrosis. Pathophysiology 28(1):155\u2013188. https:\/\/doi.org\/10.3390\/pathophysiology28010011","journal-title":"Pathophysiology"},{"issue":"3","key":"362_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S1569-1993(03)00063-8","volume":"2","author":"M Conese","year":"2003","unstructured":"Conese M, Copreni E, Gioia SD, Rinaldis PD, Fumarulo R (2003) Neutrophil recruitment and airway epithelial cell involvement in chronic cystic fibrosis lung disease. J Cyst Fibros 2(3):129\u2013135. https:\/\/doi.org\/10.1016\/S1569-1993(03)00063-8","journal-title":"J Cyst Fibros"},{"issue":"4","key":"362_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jcf.2004.06.006","volume":"3","author":"JM Courtney","year":"2004","unstructured":"Courtney JM, Ennis M, Elborn JS (2004) Cytokines and inflammatory mediators in cystic fibrosis. J Cyst Fibros 3(4):223\u2013231. https:\/\/doi.org\/10.1016\/j.jcf.2004.06.006","journal-title":"J Cyst Fibros"},{"issue":"9","key":"362_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ph17091185","volume":"17","author":"S D\u2019Orazio","year":"2024","unstructured":"D\u2019Orazio S, Mattoscio D (2024) Dysregulation of the arachidonic acid pathway in cystic fibrosis: implications for chronic inflammation and disease progression. Pharmaceuticals 17(9):1185. https:\/\/doi.org\/10.3390\/ph17091185","journal-title":"Pharmaceuticals"},{"issue":"15","key":"362_CR28","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1182\/blood-2012-04-423525","volume":"120","author":"J Dalli","year":"2012","unstructured":"Dalli J, Serhan CN (2012) Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 120(15):e60\u2013e72. https:\/\/doi.org\/10.1182\/blood-2012-04-423525","journal-title":"Blood"},{"issue":"1","key":"362_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2353\/ajpath.2010.091149","volume":"177","author":"J Dalli","year":"2010","unstructured":"Dalli J, Rosignoli G, Hayhoe RPG, Edelman A, Perretti M (2010) CFTR inhibition provokes an inflammatory response associated with an imbalance of the annexin A1 pathway. Am J Pathol 177(1):176\u2013186. https:\/\/doi.org\/10.2353\/ajpath.2010.091149","journal-title":"Am J Pathol"},{"issue":"5","key":"362_CR30","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1096\/fj.14-268441","volume":"29","author":"J Dalli","year":"2015","unstructured":"Dalli J, Ramon S, Norris PC, Colas RA, Serhan CN (2015) Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways. FASEB J 29(5):2120\u20132136. https:\/\/doi.org\/10.1096\/fj.14-268441","journal-title":"FASEB J"},{"issue":"5","key":"362_CR31","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/ppul.26334","volume":"58","author":"RC De Vuyst","year":"2023","unstructured":"De Vuyst RC, Bennard E, Kam CW, McKinzie CJ, Esther CR (2023) Elexacaftor\/tezacaftor\/ivacaftor treatment reduces airway inflammation in cystic fibrosis. Pediatr Pulmonol 58(5):1592\u20131594. https:\/\/doi.org\/10.1002\/ppul.26334","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"362_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-11-177","volume":"11","author":"A Decraene","year":"2010","unstructured":"Decraene A, Willems-Widyastuti A, Kasran A, De Boeck K, Bullens DM, Dupont LJ (2010) Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable cystic fibrosis patients. Respir Res 11(1):177. https:\/\/doi.org\/10.1186\/1465-9921-11-177","journal-title":"Respir Res"},{"issue":"5","key":"362_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019970","volume":"6","author":"P Del Porto","year":"2011","unstructured":"Del Porto P, Cifani N, Guarnieri S, Domenico EGD, Mariggi\u00f2 MA, Spadaro F, Guglietta S, Anile M, Venuta F, Quattrucci S, Ascenzioni F (2011) Dysfunctional CFTR alters the bactericidal activity of human macrophages against Pseudomonas aeruginosa. PLoS One 6(5):e19970. https:\/\/doi.org\/10.1371\/journal.pone.0019970","journal-title":"PLoS One"},{"key":"362_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1083333","volume":"14","author":"J Dodd","year":"2023","unstructured":"Dodd J, Jordan R, Makhlina M, Barnett K, Roffel A, Spana C, Obr A, Dhingra P, Kayne PS (2023) A novel oral formulation of the melanocortin-1 receptor agonist PL8177 resolves inflammation in preclinical studies of inflammatory bowel disease and is gut restricted in rats, dogs, and humans. Front Immunol 14:1083333. https:\/\/doi.org\/10.3389\/fimmu.2023.1083333","journal-title":"Front Immunol"},{"issue":"1","key":"362_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/CIRCRESAHA.121.319822","volume":"130","author":"AC Doran","year":"2022","unstructured":"Doran AC (2022) Inflammation resolution: implications for atherosclerosis. Circ Res 130(1):130\u2013148. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.319822","journal-title":"Circ Res"},{"issue":"2","key":"362_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171249","volume":"12","author":"O Eickmeier","year":"2017","unstructured":"Eickmeier O, Fussbroich D, Mueller K, Serve F, Smaczny C, Zielen S, Schubert R (2017) Pro-resolving lipid mediator resolvin D1 serves as a marker of lung disease in cystic fibrosis. PLoS One 12(2):e0171249. https:\/\/doi.org\/10.1371\/journal.pone.0171249","journal-title":"PLoS One"},{"issue":"6","key":"362_CR37","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.jcf.2021.08.007","volume":"20","author":"JS Elborn","year":"2021","unstructured":"Elborn JS, Konstan MW, Taylor-Cousar JL, Fajac I, Horsley A, Sutharsan S, Aaron SD, Daines CL, Uluer A, Downey DG, Lucidi VV, Ahuja S, Springman E, Mershon J, Grosswald R, Rowe SM (2021) Empire-CF study: a phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis. J Cyst Fibros 20(6):1026\u20131034. https:\/\/doi.org\/10.1016\/j.jcf.2021.08.007","journal-title":"J Cyst Fibros"},{"issue":"4","key":"362_CR38","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1172\/JCI1112","volume":"101","author":"VA Fadok","year":"1998","unstructured":"Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101(4):890\u2013898. https:\/\/doi.org\/10.1172\/JCI1112","journal-title":"J Clin Invest"},{"issue":"4","key":"362_CR39","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1538-7836.2004.00683.x","volume":"2","author":"A Falco","year":"2004","unstructured":"Falco A, Romano M, Iapichino L, Collura M, Dav\u00ec G (2004) Increased soluble CD40 ligand levels in cystic fibrosis. J Thromb Haemost 2(4):557\u2013560. https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00683.x","journal-title":"J Thromb Haemost"},{"issue":"3","key":"362_CR40","doi-asserted-by":"publisher","first-page":"745","DOI":"10.4049\/jimmunol.1901171","volume":"208","author":"Z Fan","year":"2022","unstructured":"Fan Z, Pitmon E, Wen L, Miller J, Ehinger E, Herro R, Liu W, Chen J, Mikulski Z, Conrad DJ, Marki A, Orecchioni M, Kumari P, Zhu YP, Marcovecchio PM, Hedrick CC, Hodges CA, Rathinam VA, Wang K, Ley K (2022) Bone marrow transplantation rescues monocyte recruitment defect and improves cystic fibrosis in mice. J Immunol 208(3):745\u2013752. https:\/\/doi.org\/10.4049\/jimmunol.1901171","journal-title":"J Immunol"},{"issue":"7","key":"362_CR41","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20212006","volume":"42","author":"CM Farinha","year":"2022","unstructured":"Farinha CM, Callebaut I (2022) Molecular mechanisms of cystic fibrosis - how mutations lead to misfunction and guide therapy. Biosci Rep 42(7):BSR20212006. https:\/\/doi.org\/10.1042\/BSR20212006","journal-title":"Biosci Rep"},{"issue":"11","key":"362_CR42","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301495R","volume":"37","author":"G Ferri","year":"2023","unstructured":"Ferri G, Serano M, Isopi E, Mucci M, Mattoscio D, Pecce R, Protasi F, Mall MA, Romano M, Recchiuti A (2023) Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. FASEB J 37(11):e23233. https:\/\/doi.org\/10.1096\/fj.202301495R","journal-title":"FASEB J"},{"issue":"4","key":"362_CR43","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/iub.175","volume":"61","author":"MK Findley","year":"2009","unstructured":"Findley MK, Koval M (2009) Regulation and roles for claudin-family tight junction proteins. IUBMB Life 61(4):431\u2013437. https:\/\/doi.org\/10.1002\/iub.175","journal-title":"IUBMB Life"},{"key":"362_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1078678","volume":"13","author":"J Garrido-Mesa","year":"2022","unstructured":"Garrido-Mesa J, Thomas BL, Dodd J, Spana C, Perretti M, Montero-Melendez T (2022) Pro-resolving and anti-arthritic properties of the MC1 selective agonist PL8177. Front Immunol 13:1078678. https:\/\/doi.org\/10.3389\/fimmu.2022.1078678","journal-title":"Front Immunol"},{"issue":"2","key":"362_CR45","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1165\/ajrcmb\/9.2.148","volume":"9","author":"RW Godfrey","year":"1993","unstructured":"Godfrey RW, Severs NJ, Jeffery PK (1993) Structural alterations of airway epithelial tight junctions in cystic fibrosis: comparison of transplant and postmortem tissue. Am J Respir Cell Mol Biol 9(2):148\u2013156. https:\/\/doi.org\/10.1165\/ajrcmb\/9.2.148","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"17","key":"362_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174128","volume":"20","author":"L Gonz\u00e1lez-Mariscal","year":"2019","unstructured":"Gonz\u00e1lez-Mariscal L, Gallego-Guti\u00e9rrez H, Gonz\u00e1lez-Gonz\u00e1lez L, Hern\u00e1ndez-Guzm\u00e1n C (2019) ZO-2 is a master regulator of gene expression, cell proliferation, cytoarchitecture, and cell size. IJMS 20(17):4128. https:\/\/doi.org\/10.3390\/ijms20174128","journal-title":"IJMS"},{"issue":"2","key":"362_CR47","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/thoraxjnl-2017-210134","volume":"73","author":"RD Gray","year":"2018","unstructured":"Gray RD, Hardisty G, Regan KH, Smith M, Robb CT, Duffin R, Mackellar A, Felton JM, Paemka L, McCullagh BN, Lucas CD, Dorward DA, McKone EF, Cooke G, Donnelly SC, Singh PK, Stoltz DA, Haslett C, McCray PB, Whyte MKB, Rossi AG, Davidson DJ (2018) Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis. Thorax 73(2):134\u2013144. https:\/\/doi.org\/10.1136\/thoraxjnl-2017-210134","journal-title":"Thorax"},{"issue":"1","key":"362_CR48","doi-asserted-by":"publisher","first-page":"L101","DOI":"10.1152\/ajplung.00018.2008","volume":"296","author":"Y Grumbach","year":"2009","unstructured":"Grumbach Y, Quynh NVT, Chiron R, Urbach V (2009) LXA4 stimulates ZO-1 expression and transepithelial electrical resistance in human airway epithelial (16HBE14o-) cells. Am J Phys Lung Cell Mol Phys 296(1):L101\u2013L108. https:\/\/doi.org\/10.1152\/ajplung.00018.2008","journal-title":"Am J Phys Lung Cell Mol Phys"},{"issue":"22","key":"362_CR49","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.164944","volume":"7","author":"D Guidone","year":"2022","unstructured":"Guidone D, Buccirossi M, Scudieri P, Genovese M, Sarnataro S, De Cegli R, Cresta F, Terlizzi V, Planelles G, Crambert G, Sermet I, Galietta LJV (2022) Airway surface hyperviscosity and defective mucociliary transport by IL-17\/TNF-\u03b1 are corrected by \u03b2-adrenergic stimulus. JCI Insight 7(22):e164944. https:\/\/doi.org\/10.1172\/jci.insight.164944","journal-title":"JCI Insight"},{"issue":"8","key":"362_CR50","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1164\/rccm.201407-1381OC","volume":"191","author":"A Hector","year":"2015","unstructured":"Hector A, Sch\u00e4fer H, P\u00f6schel S, Fischer A, Fritzsching B, Ralhan A, Carevic M, \u00d6z H, Zundel S, Hogardt M, Bakele M, Rieber N, Riethmueller J, Graepler-Mainka U, Stahl M, Bender A, Frick J-S, Mall M, Hartl D (2015) Regulatory T-cell impairment in cystic fibrosis patients with chronic Pseudomonas infection. Am J Respir Crit Care Med 191(8):914\u2013923. https:\/\/doi.org\/10.1164\/rccm.201407-1381OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"362_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26777-9","volume":"12","author":"J Hey","year":"2021","unstructured":"Hey J, Paulsen M, Toth R, Weichenhan D, Butz S, Schatterny J, Liebers R, Lutsik P, Plass C, Mall MA (2021) Epigenetic reprogramming of airway macrophages promotes polarization and inflammation in muco-obstructive lung disease. Nat Commun 12(1):6520. https:\/\/doi.org\/10.1038\/s41467-021-26777-9","journal-title":"Nat Commun"},{"issue":"11","key":"362_CR52","doi-asserted-by":"publisher","first-page":"L1053","DOI":"10.1152\/ajplung.00368.2015","volume":"310","author":"G Higgins","year":"2016","unstructured":"Higgins G, Fustero Torre C, Tyrrell J, McNally P, Harvey BJ, Urbach V (2016) Lipoxin A4 prevents tight junction disruption and delays the colonization of cystic fibrosis bronchial epithelial cells by Pseudomonas aeruginosa. Am J Phys Lung Cell Mol Phys 310(11):L1053\u2013L1061. https:\/\/doi.org\/10.1152\/ajplung.00368.2015","journal-title":"Am J Phys Lung Cell Mol Phys"},{"issue":"4","key":"362_CR53","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1569-1993(02)00104-2","volume":"1","author":"N H\u00f8iby","year":"2002","unstructured":"H\u00f8iby N (2002) Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies. J Cyst Fibros 1(4):249\u2013254. https:\/\/doi.org\/10.1016\/S1569-1993(02)00104-2","journal-title":"J Cyst Fibros"},{"issue":"4","key":"362_CR54","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jcf.2012.11.004","volume":"12","author":"N Houston","year":"2013","unstructured":"Houston N, Stewart N, Smith DS, Bell SC, Champion AC, Reid DW (2013) Sputum neutrophils in cystic fibrosis patients display a reduced respiratory burst. J Cyst Fibros 12(4):352\u2013362. https:\/\/doi.org\/10.1016\/j.jcf.2012.11.004","journal-title":"J Cyst Fibros"},{"issue":"6","key":"362_CR55","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1164\/rccm.201207-1346OC","volume":"187","author":"RG Iannitti","year":"2013","unstructured":"Iannitti RG, Carvalho A, Cunha C, De Luca A, Giovannini G, Casagrande A, Zelante T, Vacca C, Fallarino F, Puccetti P, Massi-Benedetti C, Defilippi G, Russo M, Porcaro L, Colombo C, Ratclif L, De Benedictis FM, Romani L (2013) Th17\/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines. Am J Respir Crit Care Med 187(6):609\u2013620. https:\/\/doi.org\/10.1164\/rccm.201207-1346OC","journal-title":"Am J Respir Crit Care Med"},{"key":"362_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00581","volume":"11","author":"E Isopi","year":"2020","unstructured":"Isopi E, Mattoscio D, Codagnone M, Mari VC, Lamolinara A, Patruno S, D\u2019Aurora M, Cianci E, Nespoli A, Franchi S, Gatta V, Dubourdeau M, Moretti P, Di Sabatino M, Iezzi M, Romano M, Recchiuti A (2020) Resolvin D1 reduces lung infection and inflammation activating resolution in cystic fibrosis. Front Immunol 11:581. https:\/\/doi.org\/10.3389\/fimmu.2020.00581","journal-title":"Front Immunol"},{"issue":"2","key":"362_CR57","doi-asserted-by":"publisher","first-page":"512","DOI":"10.2353\/ajpath.2010.100168","volume":"177","author":"AI Ivanov","year":"2010","unstructured":"Ivanov AI, Parkos CA, Nusrat A (2010) Cytoskeletal regulation of epithelial barrier function during inflammation. Am J Pathol 177(2):512\u2013524. https:\/\/doi.org\/10.2353\/ajpath.2010.100168","journal-title":"Am J Pathol"},{"issue":"782","key":"362_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adk9145","volume":"17","author":"F Jaudas","year":"2025","unstructured":"Jaudas F, Bartenschlager F, Shashikadze B, Santamaria G, Reichart D, Schnell A, St\u00f6ckl JB, Degroote RL, Cambra JM, Graeber SY, B\u00e4hr A, Kartmann H, Stefanska M, Liu H, Naumann-Bartsch N, Bruns H, Berges J, Hanselmann L, Stirm M, Krebs S, Deeg CA, Blum H, Schulz C, Zawada D, Janda M, Caballero-Posadas I, Kunzelmann K, Moretti A, Laugwitz K-L, Kupatt C, Saalm\u00fcller A, Fr\u00f6hlich T, Wolf E, Mall MA, Mundhenk L, Gerner W, Klymiuk N (2025) Perinatal dysfunction of innate immunity in cystic fibrosis. Sci Transl Med 17(782):eadk9145. https:\/\/doi.org\/10.1126\/scitranslmed.adk9145","journal-title":"Sci Transl Med"},{"key":"362_CR59","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-med-042921-021447","volume":"74","author":"S Jia","year":"2023","unstructured":"Jia S, Taylor-Cousar JL (2023) Cystic fibrosis modulator therapies. Annu Rev Med 74:413\u2013426. https:\/\/doi.org\/10.1146\/annurev-med-042921-021447","journal-title":"Annu Rev Med"},{"issue":"7","key":"362_CR60","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/cyto.a.22456","volume":"85","author":"J Johansson","year":"2014","unstructured":"Johansson J, Vezzalini M, Verz\u00e8 G, Caldrer S, Bolognin S, Buffelli M, Bellisola G, Tridello G, Assael BM, Melotti P, Sorio C (2014) Detection of CFTR protein in human leukocytes by flow cytometry. Cytometry A 85(7):611\u2013620. https:\/\/doi.org\/10.1002\/cyto.a.22456","journal-title":"Cytometry A"},{"issue":"4","key":"362_CR61","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1189\/jlb.1204748","volume":"80","author":"L Kang","year":"2006","unstructured":"Kang L, McIntyre KW, Gillooly KM, Yang Y, Haycock J, Roberts S, Khanna A, Herpin TF, Yu G, Wu X, Morton GC, Tuerdi H, Koplowitz B, Walker SG, Wardwell-Swanson J, Macor JE, Lawrence RM, Carlson KE (2006) A selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice. J Leukoc Biol 80(4):897\u2013904. https:\/\/doi.org\/10.1189\/jlb.1204748","journal-title":"J Leukoc Biol"},{"issue":"4","key":"362_CR62","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ni1056","volume":"5","author":"CL Karp","year":"2004","unstructured":"Karp CL, Flick LM, Park KW, Softic S, Greer TM, Keledjian R, Yang R, Uddin J, Guggino WB, Atabani SF, Belkaid Y, Xu Y, Whitsett JA, Accurso FJ, Wills-Karp M, Petasis NA (2004) Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat Immunol 5(4):388\u2013392. https:\/\/doi.org\/10.1038\/ni1056","journal-title":"Nat Immunol"},{"key":"362_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00879","volume":"11","author":"M Khalaf","year":"2020","unstructured":"Khalaf M, Scott-Ward T, Causer A, Saynor Z, Shepherd A, G\u00f3recki D, Lewis A, Laight D, Shute J (2020) Cystic fibrosis transmembrane conductance regulator (CFTR) in human lung microvascular endothelial cells controls oxidative stress, reactive oxygen-mediated cell signaling and inflammatory responses. Front Physiol 11:879. https:\/\/doi.org\/10.3389\/fphys.2020.00879","journal-title":"Front Physiol"},{"issue":"6","key":"362_CR64","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1189\/jlb.0310149","volume":"88","author":"Y Kobayashi","year":"2010","unstructured":"Kobayashi Y (2010) The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. J Leukoc Biol 88(6):1157\u20131162. https:\/\/doi.org\/10.1189\/jlb.0310149","journal-title":"J Leukoc Biol"},{"issue":"2","key":"362_CR65","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jcf.2013.12.009","volume":"13","author":"MW Konstan","year":"2014","unstructured":"Konstan MW, D\u00f6ring G, Heltshe SL, Lands LC, Hilliard KA, Koker P, Bhattacharya S, Staab A, Hamilton A (2014) A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis. J Cyst Fibros 13(2):148\u2013155. https:\/\/doi.org\/10.1016\/j.jcf.2013.12.009","journal-title":"J Cyst Fibros"},{"key":"362_CR66","doi-asserted-by":"publisher","unstructured":"Konstan MW, Tolle JJ, DiMango E, Flume PA, Usansky H, Teper A, Ramirez CN, Flarakos J, Basso J, Li S, Vergara M (2025) A Phase IIa, Single-Blind, Placebo-Controlled, Parallel-Group Study to Assess Safety, Tolerability, and Pharmacokinetics\/Pharmacodynamics of Brensocatib in Adults with Cystic Fibrosis. Clin Pharmacokinet 64(10):1561\u20131574. https:\/\/doi.org\/10.1007\/s40262-025-01550-z","DOI":"10.1007\/s40262-025-01550-z"},{"issue":"22","key":"362_CR67","doi-asserted-by":"publisher","first-page":"14910","DOI":"10.1074\/jbc.C800074200","volume":"283","author":"M Korpal","year":"2008","unstructured":"Korpal M, Lee ES, Hu G, Kang Y (2008) The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283(22):14910\u201314914. https:\/\/doi.org\/10.1074\/jbc.C800074200","journal-title":"J Biol Chem"},{"key":"362_CR68","doi-asserted-by":"publisher","unstructured":"Lands LC, Stanojevic S (2019) Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis. Cochrane Database Syst Rev 9(9). https:\/\/doi.org\/10.1002\/14651858.CD001505.pub5","DOI":"10.1002\/14651858.CD001505.pub5"},{"issue":"6","key":"362_CR69","doi-asserted-by":"publisher","first-page":"00312","DOI":"10.1183\/23120541.00312-2024","volume":"10","author":"SM Law","year":"2024","unstructured":"Law SM, Hardisty G, Gillan JL, Robinson NJ, Davidson DJ, Whyte MKB, Dransfield I, Gray RD (2024) Neutrophil extracellular traps are associated with airways inflammation and increased severity of lung disease in cystic fibrosis. ERJ Open Res 10(6):00312\u201302024. https:\/\/doi.org\/10.1183\/23120541.00312-2024","journal-title":"ERJ Open Res"},{"issue":"5","key":"362_CR70","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1165\/rcmb.2009-0420OC","volume":"44","author":"S-N Lee","year":"2011","unstructured":"Lee S-N, Ryu J-H, Joo J-H, Choi Y-H, Lee H-J, Kim Y-J, Kim K-B, Yoon J-H (2011) \u03b1-Melanocyte-stimulating hormone inhibits tumor necrosis factor \u03b1-stimulated MUC5AC expression in human nasal epithelial cells. Am J Respir Cell Mol Biol 44(5):716\u2013724. https:\/\/doi.org\/10.1165\/rcmb.2009-0420OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"362_CR71","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.redox.2018.07.001","volume":"18","author":"C-W Lee","year":"2018","unstructured":"Lee C-W, Wu C-H, Chiang Y-C, Chen Y-L, Chang K-T, Chuang C-C, Lee I-T (2018) Carbon monoxide releasing molecule-2 attenuates Pseudomonas aeruginosa-induced ROS-dependent ICAM-1 expression in human pulmonary alveolar epithelial cells. Redox Biol 18:93\u2013103. https:\/\/doi.org\/10.1016\/j.redox.2018.07.001","journal-title":"Redox Biol"},{"issue":"10","key":"362_CR72","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1515\/hsz-2016-0180","volume":"397","author":"G Leoni","year":"2016","unstructured":"Leoni G, Nusrat A (2016) Annexin A1: shifting the balance towards resolution and repair. Biol Chem 397(10):971\u2013979. https:\/\/doi.org\/10.1515\/hsz-2016-0180","journal-title":"Biol Chem"},{"issue":"7","key":"362_CR73","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1021\/acs.jmedchem.6b01153","volume":"61","author":"K Ling","year":"2018","unstructured":"Ling K, Men F, Wang W-C, Zhou Y-Q, Zhang H-W, Ye D-W (2018) Carbon monoxide and its controlled release: therapeutic application, detection, and development of carbon monoxide releasing molecules (CORMs): miniperspective. J Med Chem 61(7):2611\u20132635. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01153","journal-title":"J Med Chem"},{"issue":"6","key":"362_CR74","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/BF02256327","volume":"10","author":"C-Y Liu","year":"2003","unstructured":"Liu C-Y, Liu Y-H, Lin S-M, Yu C-T, Wang C-H, Lin H-C, Lin C-H, Kuo H-P (2003) Apoptotic neutrophils undergoing secondary necrosis induce human lung epithelial cell detachment. J Biomed Sci 10(6):746\u2013756. https:\/\/doi.org\/10.1007\/BF02256327","journal-title":"J Biomed Sci"},{"key":"362_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113167","volume":"213","author":"M Maciuszek","year":"2021","unstructured":"Maciuszek M, Cacace A, Brennan E, Godson C, Chapman TM (2021) Recent advances in the design and development of formyl peptide receptor 2 (FPR2\/ALX) agonists as pro-resolving agents with diverse therapeutic potential. Eur J Med Chem 213:113167. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113167","journal-title":"Eur J Med Chem"},{"issue":"9","key":"362_CR76","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1136\/thorax-2024-222242","volume":"80","author":"RE Maher","year":"2025","unstructured":"Maher RE, Cytlak-Chaudhuri UM, Aleem S, Barry P, Brice DP, Caama\u00f1o Guti\u00e9rrez E, Driver K, Emmott E, Rothwell A, Smith E, Travis M, Lee D, McNamara PS, Waller I, Smith JA, Jones A, Lord RW (2025) Effect of elexacaftor\/tezacaftor\/ivacaftor on systemic inflammation in cystic fibrosis. Thorax 80(9):604\u2013615. https:\/\/doi.org\/10.1136\/thorax-2024-222242","journal-title":"Thorax"},{"issue":"1","key":"362_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00538-6","volume":"10","author":"MA Mall","year":"2024","unstructured":"Mall MA, Burgel P-R, Castellani C, Davies JC, Salathe M, Taylor-Cousar JL (2024) Cystic fibrosis. Nat Rev Dis Primers 10(1):53. https:\/\/doi.org\/10.1038\/s41572-024-00538-6","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"362_CR78","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.4049\/jimmunol.1900899","volume":"203","author":"A Margraf","year":"2019","unstructured":"Margraf A, Zarbock A (2019) Platelets in Inflammation and Resolution. JI 203(9):2357\u20132367. https:\/\/doi.org\/10.4049\/jimmunol.1900899","journal-title":"JI"},{"issue":"14","key":"362_CR79","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1182\/blood.2021012295","volume":"139","author":"A Margraf","year":"2022","unstructured":"Margraf A, Lowell CA, Zarbock A (2022) Neutrophils in acute inflammation: current concepts and translational implications. Blood 139(14):2130\u20132144. https:\/\/doi.org\/10.1182\/blood.2021012295","journal-title":"Blood"},{"issue":"10","key":"362_CR80","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1096\/fj.10-159921","volume":"24","author":"D Mattoscio","year":"2010","unstructured":"Mattoscio D, Evangelista V, De Cristofaro R, Recchiuti A, Pandolfi A, Di Silvestre S, Manarini S, Martelli N, Rocca B, Petrucci G, Angelini DF, Battistini L, Robuffo I, Pensabene T, Pieroni L, Furnari ML, Pardo F, Quattrucci S, Lancellotti S, Davi G, Romano M (2010) Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response. FASEB J 24(10):3970\u20133980. https:\/\/doi.org\/10.1096\/fj.10-159921","journal-title":"FASEB J"},{"issue":"19","key":"362_CR81","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1111\/febs.70050","volume":"292","author":"D Mattoscio","year":"2025","unstructured":"Mattoscio D, Baeza LA, Bai H, Colangelo T, Castagnozzi S, Marzotto M, Cufaro MC, Lotti V, Yuan Y-C, Mucci M, Si L, Zuccarini M, Tredicine M, D\u2019Orazio S, Pieragostino D, Del Boccio P, Sorio C, Trerotola M, Romano M, Plebani R (2025) Inflammation and epithelial-mesenchymal transition in a CFTR-depleted human bronchial epithelial cell line revealed by proteomics and human organ-on-a-chip. FEBS J 292(19):5086\u20135104. https:\/\/doi.org\/10.1111\/febs.70050","journal-title":"FEBS J"},{"issue":"5","key":"362_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0321996","volume":"20","author":"A Maupas","year":"2025","unstructured":"Maupas A, Muggeo A, Vermeulen P, Moussalih S, Sage E, Luczka-Maj\u00e9rus E, Coraux C, Guillard T (2025) Roscovitine enhances the bactericidal activity of the airway surface liquid of the cystic fibrosis bronchial epithelium but does not protect against Pseudomonas aeruginosa infection. PLoS One 20(5):e0321996. https:\/\/doi.org\/10.1371\/journal.pone.0321996","journal-title":"PLoS One"},{"issue":"7","key":"362_CR83","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/thx.2008.096834","volume":"63","author":"DJ McKeon","year":"2008","unstructured":"McKeon DJ, Condliffe AM, Cowburn AS, Cadwallader KC, Farahi N, Bilton D, Chilvers ER (2008) Prolonged survival of neutrophils from patients with F508 CFTR mutations. Thorax 63(7):660\u2013661. https:\/\/doi.org\/10.1136\/thx.2008.096834","journal-title":"Thorax"},{"issue":"6","key":"362_CR84","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1183\/09031936.00089709","volume":"35","author":"DJ McKeon","year":"2010","unstructured":"McKeon DJ, Cadwallader KA, Idris S, Cowburn AS, Pasteur MC, Barker H, Haworth CS, Bilton D, Chilvers ER, Condliffe AM (2010) Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation. Eur Respir J 35(6):1264\u20131272. https:\/\/doi.org\/10.1183\/09031936.00089709","journal-title":"Eur Respir J"},{"issue":"4","key":"362_CR85","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000444256","volume":"8","author":"L Meijer","year":"2016","unstructured":"Meijer L, Nelson DJ, Riazanski V, Gabdoulkhakova AG, Hery-Arnaud G, Le Berre R, Loa\u00ebc N, Oumata N, Galons H, Nowak E, Gueganton L, Doroth\u00e9e G, Prochazkova M, Hall B, Kulkarni AB, Gray RD, Rossi AG, Witko-Sarsat V, Norez C, Becq F, Ravel D, Mottier D, Rault G (2016) Modulating innate and adaptive immunity by (R)-roscovitine: potential therapeutic opportunity in cystic fibrosis. J Innate Immun 8(4):330\u2013349. https:\/\/doi.org\/10.1159\/000444256","journal-title":"J Innate Immun"},{"issue":"3","key":"362_CR86","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jcf.2021.10.013","volume":"21","author":"L Meijer","year":"2022","unstructured":"Meijer L, Hery-Arnaud G, Leven C, Nowak E, Hillion S, Renaudineau Y, Durieu I, Chiron R, Prevotat A, Fajac I, Hubert D, Murris-Espin M, Huge S, Danner-Boucher I, Ravoninjatovo B, Leroy S, Macey J, Urban T, Rault G, Mottier D, Berre RL (2022) Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study. J Cyst Fibros 21(3):529\u2013536. https:\/\/doi.org\/10.1016\/j.jcf.2021.10.013","journal-title":"J Cyst Fibros"},{"issue":"19","key":"362_CR87","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","volume":"381","author":"PG Middleton","year":"2019","unstructured":"Middleton PG, Mall MA, D\u0159ev\u00ednek P, Lands LC, McKone EF, Polineni D, Ramsey BW, Taylor-Cousar JL, Tullis E, Vermeulen F, Marigowda G, McKee CM, Moskowitz SM, Nair N, Savage J, Simard C, Tian S, Waltz D, Xuan F, Rowe SM, Jain R (2019) Elexacaftor\u2013tezacaftor\u2013ivacaftor for cystic fibrosis with a single Phe508del allele. N Engl J Med 381(19):1809\u20131819. https:\/\/doi.org\/10.1056\/NEJMoa1908639","journal-title":"N Engl J Med"},{"issue":"1","key":"362_CR88","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ajpath.2011.03.042","volume":"179","author":"T Montero-Melendez","year":"2011","unstructured":"Montero-Melendez T, Patel HB, Seed M, Nielsen S, Jonassen TEN, Perretti M (2011) The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties. Am J Pathol 179(1):259\u2013269. https:\/\/doi.org\/10.1016\/j.ajpath.2011.03.042","journal-title":"Am J Pathol"},{"issue":"4","key":"362_CR89","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/cpt.980","volume":"104","author":"MP Motwani","year":"2018","unstructured":"Motwani MP, Bennett F, Norris PC, Maini AA, George MJ, Newson J, Henderson A, Hobbs AJ, Tepper M, White B, Serhan CN, MacAllister R, Gilroy DW (2018) Potent anti-inflammatory and pro-resolving effects of anabasum in a human model of self-resolving acute inflammation. Clin Pharmacol Ther 104(4):675\u2013686. https:\/\/doi.org\/10.1002\/cpt.980","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"362_CR90","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/JLB.3A0520-193RR","volume":"108","author":"HP Ng","year":"2020","unstructured":"Ng HP, Jennings S, Wellems D, Sun F, Xu J, Nauseef WM, Wang G (2020) Myeloid CFTR loss-of-function causes persistent neutrophilic inflammation in cystic fibrosis. J Leukoc Biol 108(6):1777\u20131785. https:\/\/doi.org\/10.1002\/JLB.3A0520-193RR","journal-title":"J Leukoc Biol"},{"issue":"12","key":"362_CR91","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1182\/blood-2004-06-2098","volume":"105","author":"BP O\u2019Sullivan","year":"2005","unstructured":"O\u2019Sullivan BP, Linden MD, Frelinger AL, Barnard MR, Spencer-Manzon M, Morris JE, Salem RO, Laposata M, Michelson AD (2005) Platelet activation in cystic fibrosis. Blood 105(12):4635\u20134641. https:\/\/doi.org\/10.1182\/blood-2004-06-2098","journal-title":"Blood"},{"issue":"3","key":"362_CR92","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000488914","volume":"10","author":"JC Onyiah","year":"2018","unstructured":"Onyiah JC, Schaefer REM, Colgan SP (2018) A central role for heme oxygenase-1 in the control of intestinal epithelial chemokine expression. J Innate Immun 10(3):228\u2013238. https:\/\/doi.org\/10.1159\/000488914","journal-title":"J Innate Immun"},{"issue":"5","key":"362_CR93","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/emmm.201202382","volume":"5","author":"A Ortega-Gomez","year":"2013","unstructured":"Ortega-Gomez A, Perretti M, Soehnlein O (2013) Resolution of inflammation: an integrated view. EMBO Mol Med 5(5):661\u2013674. https:\/\/doi.org\/10.1002\/emmm.201202382","journal-title":"EMBO Mol Med"},{"issue":"4","key":"362_CR94","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1172\/JCI129635","volume":"130","author":"G Ortiz-Mu\u00f1oz","year":"2020","unstructured":"Ortiz-Mu\u00f1oz G, Yu MA, Lefran\u00e7ais E, Mallavia B, Valet C, Tian JJ, Ranucci S, Wang KM, Liu Z, Kwaan N, Dawson D, Kleinhenz ME, Khasawneh FT, Haggie PM, Verkman AS, Looney MR (2020) Cystic fibrosis transmembrane conductance regulator dysfunction in platelets drives lung hyperinflammation. J Clin Invest 130(4):2041\u20132053. https:\/\/doi.org\/10.1172\/JCI129635","journal-title":"J Clin Invest"},{"issue":"5","key":"362_CR95","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1089\/ars.2011.3893","volume":"15","author":"CE Overgaard","year":"2011","unstructured":"Overgaard CE, Daugherty BL, Mitchell LA, Koval M (2011) Claudins: control of barrier function and regulation in response to oxidant stress. Antioxid Redox Signal 15(5):1179\u20131193. https:\/\/doi.org\/10.1089\/ars.2011.3893","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"362_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111797","volume":"41","author":"HH \u00d6z","year":"2022","unstructured":"\u00d6z HH, Cheng E-C, Di Pietro C, Tebaldi T, Biancon G, Zeiss C, Zhang P-X, Huang PH, Esquibies SS, Britto CJ, Schupp JC, Murray TS, Halene S, Krause DS, Egan ME, Bruscia EM (2022) Recruited monocytes\/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis. Cell Rep 41(11):111797. https:\/\/doi.org\/10.1016\/j.celrep.2022.111797","journal-title":"Cell Rep"},{"issue":"4","key":"362_CR97","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jcf.2017.03.007","volume":"16","author":"L Paemka","year":"2017","unstructured":"Paemka L, McCullagh BN, Abou Alaiwa MH, Stoltz DA, Dong Q, Randak CO, Gray RD, McCray PB (2017) Monocyte derived macrophages from CF pigs exhibit increased inflammatory responses at birth. J Cyst Fibros 16(4):471\u2013474. https:\/\/doi.org\/10.1016\/j.jcf.2017.03.007","journal-title":"J Cyst Fibros"},{"issue":"34","key":"362_CR98","doi-asserted-by":"publisher","first-page":"10260","DOI":"10.1021\/bi060490t","volume":"45","author":"RG Painter","year":"2006","unstructured":"Painter RG, Valentine VG, Lanson NA, Leidal K, Zhang Q, Lombard G, Thompson C, Viswanathan A, Nauseef WM, Wang G, Wang G (2006) CFTR expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry 45(34):10260\u201310269. https:\/\/doi.org\/10.1021\/bi060490t","journal-title":"Biochemistry"},{"key":"362_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2025.106968","volume":"177","author":"ABM Pereira","year":"2025","unstructured":"Pereira ABM, Gontijo BA, Tanaka SCSV, de Vito FB, de Souza HM, da Silva PR, Rogerio A d P (2025) Aspirin-triggered RvD1 (AT-RvD1) modulates epithelial-mesenchymal transition on bronchial epithelial cells stimulated with cigarette smoke extract. Prostaglandins Other Lipid Mediat 177:106968. https:\/\/doi.org\/10.1016\/j.prostaglandins.2025.106968","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"6","key":"362_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmr.2025.100097","volume":"77","author":"M Perretti","year":"2025","unstructured":"Perretti M, Montero-Melendez T (2025) Resolution pharmacology: state-of-the-art and therapeutic landscape. Pharmacol Rev 77(6):100097. https:\/\/doi.org\/10.1016\/j.pharmr.2025.100097","journal-title":"Pharmacol Rev"},{"issue":"11","key":"362_CR101","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.tips.2015.07.007","volume":"36","author":"M Perretti","year":"2015","unstructured":"Perretti M, Leroy X, Bland EJ, Montero-Melendez T (2015) Resolution pharmacology: opportunities for therapeutic innovation in inflammation. Trends Pharmacol Sci 36(11):737\u2013755. https:\/\/doi.org\/10.1016\/j.tips.2015.07.007","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"362_CR103","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1074\/jbc.M114.592352","volume":"290","author":"AM Pierdomenico","year":"2015","unstructured":"Pierdomenico AM, Recchiuti A, Simiele F, Codagnone M, Mari VC, Dav\u00ec G, Romano M (2015) MicroRNA-181b regulates ALX\/FPR2 receptor expression and proresolution signaling in human macrophages. J Biol Chem 290(6):3592\u20133600. https:\/\/doi.org\/10.1074\/jbc.M114.592352","journal-title":"J Biol Chem"},{"issue":"1","key":"362_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14055-y","volume":"7","author":"AM Pierdomenico","year":"2017","unstructured":"Pierdomenico AM, Patruno S, Codagnone M, Simiele F, Mari VC, Plebani R, Recchiuti A, Romano M (2017) microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. Sci Rep 7(1):13519. https:\/\/doi.org\/10.1038\/s41598-017-14055-y","journal-title":"Sci Rep"},{"issue":"11","key":"362_CR105","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/labinvest.2017.74","volume":"97","author":"R Plebani","year":"2017","unstructured":"Plebani R, Tripaldi R, Lanuti P, Recchiuti A, Patruno S, Di Silvestre S, Simeone P, Anile M, Venuta F, Prioletta M, Mucilli F, Del Porto P, Marchisio M, Pandolfi A, Romano M (2017) Establishment and long-term culture of human cystic fibrosis endothelial cells. Lab Investig 97(11):1375\u20131384. https:\/\/doi.org\/10.1038\/labinvest.2017.74","journal-title":"Lab Investig"},{"issue":"4","key":"362_CR106","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jcf.2021.10.004","volume":"21","author":"R Plebani","year":"2022","unstructured":"Plebani R, Potla R, Soong M, Bai H, Izadifar Z, Jiang A, Travis RN, Belgur C, Dinis A, Cartwright MJ, Prantil-Baun R, Jolly P, Gilpin SE, Romano M, Ingber DE (2022) Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip. J Cyst Fibros 21(4):606\u2013615. https:\/\/doi.org\/10.1016\/j.jcf.2021.10.004","journal-title":"J Cyst Fibros"},{"issue":"7","key":"362_CR107","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1182\/blood-2014-02-555268","volume":"124","author":"K Pohl","year":"2014","unstructured":"Pohl K, Hayes E, Keenan J, Henry M, Meleady P, Molloy K, Jundi B, Bergin DA, McCarthy C, McElvaney OJ, White MM, Clynes M, Reeves EP, McElvaney NG (2014) A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy. Blood 124(7):999\u20131009. https:\/\/doi.org\/10.1182\/blood-2014-02-555268","journal-title":"Blood"},{"issue":"4","key":"362_CR108","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1378\/chest.12-1934","volume":"143","author":"S Poore","year":"2013","unstructured":"Poore S, Berry B, Eidson D, McKie KT, Harris RA (2013) Evidence of vascular endothelial dysfunction in young patients with cystic fibrosis. Chest 143(4):939\u2013945. https:\/\/doi.org\/10.1378\/chest.12-1934","journal-title":"Chest"},{"issue":"10","key":"362_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03119-z","volume":"11","author":"MC Quaresma","year":"2020","unstructured":"Quaresma MC, Pankonien I, Clarke LA, Sousa LS, Silva IAL, Railean V, Dou\u0161ov\u00e1 T, Fuxe J, Amaral MD (2020) Mutant CFTR drives TWIST1 mediated epithelial-mesenchymal transition. Cell Death Dis 11(10):920. https:\/\/doi.org\/10.1038\/s41419-020-03119-z","journal-title":"Cell Death Dis"},{"issue":"7","key":"362_CR110","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1096\/fj.13-248393","volume":"28","author":"A Recchiuti","year":"2014","unstructured":"Recchiuti A, Codagnone M, Pierdomenico AM, Rossi C, Mari VC, Cianci E, Simiele F, Gatta V, Romano M (2014) Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. FASEB J 28(7):3090\u20133102. https:\/\/doi.org\/10.1096\/fj.13-248393","journal-title":"FASEB J"},{"key":"362_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00252","volume":"10","author":"A Recchiuti","year":"2019","unstructured":"Recchiuti A, Mattoscio D, Isopi E (2019) Roles, actions, and therapeutic potential of specialized pro-resolving lipid mediators for the treatment of inflammation in cystic fibrosis. Front Pharmacol 10:252. https:\/\/doi.org\/10.3389\/fphar.2019.00252","journal-title":"Front Pharmacol"},{"key":"362_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01129","volume":"11","author":"A Recchiuti","year":"2020","unstructured":"Recchiuti A, Patruno S, Plebani R, Romano M (2020) The resolution approach to cystic fibrosis inflammation. Front Pharmacol 11:1129. https:\/\/doi.org\/10.3389\/fphar.2020.01129","journal-title":"Front Pharmacol"},{"issue":"2","key":"362_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11020212","volume":"11","author":"NM Reddy","year":"2022","unstructured":"Reddy NM, Tamatam CM, Aparna A, Reddy SP (2022) Nrf2 is required for optimal alveolar-macrophage-mediated apoptotic neutrophil clearance after oxidant injury. Antioxidants (Basel) 11(2):212. https:\/\/doi.org\/10.3390\/antiox11020212","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"362_CR114","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1183\/09031936.00106013","volume":"44","author":"FC Ringholz","year":"2014","unstructured":"Ringholz FC, Buchanan PJ, Clarke DT, Millar RG, McDermott M, Linnane B, Harvey BJ, McNally P, Urbach V (2014) Reduced 15-lipoxygenase 2 and lipoxin A4\/leukotriene B4 ratio in children with cystic fibrosis. Eur Respir J 44(2):394\u2013404. https:\/\/doi.org\/10.1183\/09031936.00106013","journal-title":"Eur Respir J"},{"issue":"5","key":"362_CR115","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jcf.2017.11.017","volume":"17","author":"FC Ringholz","year":"2018","unstructured":"Ringholz FC, Higgins G, Hatton A, Sassi A, Moukachar A, Fustero-Torre C, Hollenhorst M, Sermet-Gaudelus I, Harvey BJ, McNally P, Urbach V (2018) Resolvin D1 regulates epithelial ion transport and inflammation in cystic fibrosis airways. J Cyst Fibros 17(5):607\u2013615. https:\/\/doi.org\/10.1016\/j.jcf.2017.11.017","journal-title":"J Cyst Fibros"},{"key":"362_CR1000","doi-asserted-by":"publisher","unstructured":"Riordan J R, Rommens J M, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou J L, Drumm M L, Iannuzzi M C, Collins F S, Chee Tsui L C (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245(4922):1066\u20131073. https:\/\/doi.org\/10.1126\/science.2475911","DOI":"10.1126\/science.2475911"},{"issue":"12","key":"362_CR116","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.it.2023.10.004","volume":"44","author":"P Rodr\u00edguez-Morales","year":"2023","unstructured":"Rodr\u00edguez-Morales P, Franklin RA (2023) Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis. Trends Immunol 44(12):986\u2013998. https:\/\/doi.org\/10.1016\/j.it.2023.10.004","journal-title":"Trends Immunol"},{"key":"362_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1655479","volume":"16","author":"CS Rodrigues","year":"2025","unstructured":"Rodrigues CS, Canto M, Torres R, Railean V, Ramalho SS, Farinha CM, Pankonien I, Amaral MD (2025) CFTR ion transport deficiency primes the epithelium for partial epithelial-mesenchymal transition in cystic fibrosis. Front Pharmacol 16:1655479. https:\/\/doi.org\/10.3389\/fphar.2025.1655479","journal-title":"Front Pharmacol"},{"issue":"S3","key":"362_CR118","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1002\/ppul.24129","volume":"53","author":"EA Roesch","year":"2018","unstructured":"Roesch EA, Nichols DP, Chmiel JF (2018) Inflammation in cystic fibrosis: an update. Pediatr Pulmonol 53(S3):S30\u2013S50. https:\/\/doi.org\/10.1002\/ppul.24129","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"362_CR119","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1055\/s-0037-1616736","volume":"86","author":"M Romano","year":"2001","unstructured":"Romano M, Collura M, Lapichino L, Pardo F, Falco A, Chiesa PL, Caimi G, Dav\u00ec G (2001) Endothelial perturbation in cystic fibrosis. Thromb Haemost 86(6):1363\u20131367","journal-title":"Thromb Haemost"},{"issue":"S1","key":"362_CR120","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1002\/ppul.25075","volume":"56","author":"DB Sanders","year":"2021","unstructured":"Sanders DB, Chmiel JF (2021) Drug development for cystic fibrosis. Pediatr Pulmonol 56(S1):S10\u2013S22. https:\/\/doi.org\/10.1002\/ppul.25075","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"362_CR121","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02153-2022","volume":"62","author":"L Schaupp","year":"2023","unstructured":"Schaupp L, Addante A, V\u00f6ller M, Fentker K, Kuppe A, Bardua M, Duerr J, Piehler L, R\u00f6hmel J, Thee S, Kirchner M, Ziehm M, Lauster D, Haag R, Gradzielski M, Stahl M, Mertins P, Boutin S, Graeber SY, Mall MA (2023) Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis. Eur Respir J 62(2):2202153. https:\/\/doi.org\/10.1183\/13993003.02153-2022","journal-title":"Eur Respir J"},{"issue":"7","key":"362_CR122","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1172\/JCI97943","volume":"128","author":"CN Serhan","year":"2018","unstructured":"Serhan CN, Levy BD (2018) Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest 128(7):2657\u20132669. https:\/\/doi.org\/10.1172\/JCI97943","journal-title":"J Clin Invest"},{"issue":"1","key":"362_CR123","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1146\/annurev-physiol-020924-033209","volume":"87","author":"CN Serhan","year":"2025","unstructured":"Serhan CN, Levy BD (2025) Pro-resolving lipid mediators in the respiratory system. Annu Rev Physiol 87(1):491\u2013512. https:\/\/doi.org\/10.1146\/annurev-physiol-020924-033209","journal-title":"Annu Rev Physiol"},{"issue":"12","key":"362_CR124","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/ni1276","volume":"6","author":"CN Serhan","year":"2005","unstructured":"Serhan CN, Savill J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6(12):1191\u20131197. https:\/\/doi.org\/10.1038\/ni1276","journal-title":"Nat Immunol"},{"issue":"4","key":"362_CR125","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00408-022-00546-x","volume":"200","author":"AH Shahraki","year":"2022","unstructured":"Shahraki AH, Tian R, Zhang C, Fregien NL, Bejarano P, Mirsaeidi M (2022) Anti-inflammatory properties of the alpha-melanocyte-stimulating hormone in models of granulomatous inflammation. Lung 200(4):463\u2013472. https:\/\/doi.org\/10.1007\/s00408-022-00546-x","journal-title":"Lung"},{"issue":"suppl 1","key":"362_CR126","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1590\/S0074-02762005000900012","volume":"100","author":"CA Shaw","year":"2005","unstructured":"Shaw CA, Taylor EL, Megson IL, Rossi AG (2005) Nitric oxide and the resolution of inflammation: implications for atherosclerosis. Mem Inst Oswaldo Cruz 100(suppl 1):67\u201371. https:\/\/doi.org\/10.1590\/S0074-02762005000900012","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"3","key":"362_CR127","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/ppul.26261","volume":"58","author":"S Sheikh","year":"2023","unstructured":"Sheikh S, Britt RD, Ryan-Wenger NA, Khan AQ, Lewis BW, Gushue C, Ozuna H, Jaganathan D, McCoy K, Kopp BT (2023) Impact of elexacaftor\u2013tezacaftor\u2013ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis. Pediatr Pulmonol 58(3):825\u2013833. https:\/\/doi.org\/10.1002\/ppul.26261","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"362_CR128","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.4049\/jimmunol.179.6.3407","volume":"179","author":"T Shibata","year":"2007","unstructured":"Shibata T, Nagata K, Kobayashi Y (2007) Cutting edge: a critical role of nitrogen oxide in preventing inflammation upon apoptotic cell clearance. J Immunol 179(6):3407\u20133411. https:\/\/doi.org\/10.4049\/jimmunol.179.6.3407","journal-title":"J Immunol"},{"issue":"10290","key":"362_CR129","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","volume":"397","author":"M Shteinberg","year":"2021","unstructured":"Shteinberg M, Haq IJ, Polineni D, Davies JC (2021) Cystic fibrosis. Lancet 397(10290):2195\u20132211. https:\/\/doi.org\/10.1016\/S0140-6736(20)32542-3","journal-title":"Lancet"},{"key":"362_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.915261","volume":"13","author":"M Shum","year":"2022","unstructured":"Shum M, London CM, Briottet M, Sy KA, Baillif V, Philippe R, Zare A, Ghorbani-Dalini S, Remus N, Tarze A, Escabasse V, Epaud R, Dubourdeau M, Urbach V (2022) CF patients\u2019 airway epithelium and sex contribute to biosynthesis defects of pro-resolving lipids. Front Immunol 13:915261. https:\/\/doi.org\/10.3389\/fimmu.2022.915261","journal-title":"Front Immunol"},{"issue":"9","key":"362_CR131","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075667","volume":"8","author":"K Simonin-Le Jeune","year":"2013","unstructured":"Simonin-Le Jeune K, Le Jeune A, Jouneau S, Belleguic C, Roux P-F, Jaguin M, Dimanche-Boitre M-T, Lecureur V, Leclercq C, Desrues B, Brinchault G, Gangneux J-P, Martin-Chouly C (2013) Impaired functions of macrophage from cystic fibrosis patients: CD11b, TLR-5 decrease and sCD14, inflammatory cytokines increase. PLoS ONE 8(9):e75667. https:\/\/doi.org\/10.1371\/journal.pone.0075667","journal-title":"PLoS ONE"},{"key":"362_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1202009","volume":"14","author":"LJM Slimmen","year":"2023","unstructured":"Slimmen LJM, Giacalone VD, Schofield C, Horati H, Mana\u00ef BHAN, Estev\u00e3o SC, Garratt LW, Peng L, Tirouvanziam R, Janssens HM, Unger WWJ (2023) Airway macrophages display decreased expression of receptors mediating and regulating scavenging in early cystic fibrosis lung disease. Front Immunol 14:1202009. https:\/\/doi.org\/10.3389\/fimmu.2023.1202009","journal-title":"Front Immunol"},{"issue":"10","key":"362_CR133","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1164\/rccm.201510-1922OC","volume":"193","author":"C Sorio","year":"2016","unstructured":"Sorio C, Montresor A, Bolomini-Vittori M, Caldrer S, Rossi B, Dusi S, Angiari S, Johansson JE, Vezzalini M, Leal T, Calcaterra E, Assael BM, Melotti P, Laudanna C (2016) Mutations of cystic fibrosis transmembrane conductance regulator gene cause a monocyte-selective adhesion deficiency. Am J Respir Crit Care Med 193(10):1123\u20131133. https:\/\/doi.org\/10.1164\/rccm.201510-1922OC","journal-title":"Am J Respir Crit Care Med"},{"key":"362_CR134","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1067134","volume":"2018","author":"M Stolarczyk","year":"2018","unstructured":"Stolarczyk M, Scholte BJ (2018) The EGFR-ADAM17 axis in chronic obstructive pulmonary disease and cystic fibrosis lung pathology. Mediat Inflamm 2018:1067134. https:\/\/doi.org\/10.1155\/2018\/1067134","journal-title":"Mediat Inflamm"},{"issue":"3","key":"362_CR135","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jcf.2009.12.004","volume":"9","author":"A Sturm","year":"2010","unstructured":"Sturm A, Hebestreit H, Koenig C, Walter U, Grossmann R (2010) Platelet proinflammatory activity in clinically stable patients with CF starts in early childhood. J Cyst Fibros 9(3):179\u2013186. https:\/\/doi.org\/10.1016\/j.jcf.2009.12.004","journal-title":"J Cyst Fibros"},{"key":"362_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8239258","volume":"2016","author":"MA Sugimoto","year":"2016","unstructured":"Sugimoto MA, Vago JP, Teixeira MM, Sousa LP (2016) Annexin A1 and the resolution of inflammation: modulation of neutrophil recruitment, apoptosis, and clearance. J Immunol Res 2016:1\u201313. https:\/\/doi.org\/10.1155\/2016\/8239258","journal-title":"J Immunol Res"},{"issue":"3","key":"362_CR137","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1172\/JCI83922","volume":"126","author":"XX Tang","year":"2016","unstructured":"Tang XX, Ostedgaard LS, Hoegger MJ, Moninger TO, Karp PH, McMenimen JD, Choudhury B, Varki A, Stoltz DA, Welsh MJ (2016) Acidic pH increases airway surface liquid viscosity in cystic fibrosis. J Clin Invest 126(3):879\u2013891. https:\/\/doi.org\/10.1172\/JCI83922","journal-title":"J Clin Invest"},{"issue":"4","key":"362_CR138","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jcf.2017.03.011","volume":"16","author":"AA Tarique","year":"2017","unstructured":"Tarique AA, Sly PD, Holt PG, Bosco A, Ware RS, Logan J, Bell SC, Wainwright CE, Fantino E (2017) CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis. J Cyst Fibros 16(4):475\u2013482. https:\/\/doi.org\/10.1016\/j.jcf.2017.03.011","journal-title":"J Cyst Fibros"},{"issue":"3","key":"362_CR139","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jcf.2018.07.012","volume":"18","author":"AA Tarique","year":"2019","unstructured":"Tarique AA, Sly PD, Cardenas DG, Luo L, Stow JL, Bell SC, Wainwright CE, Fantino E (2019) Differential expression of genes and receptors in monocytes from patients with cystic fibrosis. J Cyst Fibros 18(3):342\u2013348. https:\/\/doi.org\/10.1016\/j.jcf.2018.07.012","journal-title":"J Cyst Fibros"},{"issue":"4","key":"362_CR140","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1378\/chest.117.4.1085","volume":"117","author":"SR Thomas","year":"2000","unstructured":"Thomas SR, Kharitonov SA, Scott SF, Hodson ME, Barnes PJ (2000) Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. Chest 117(4):1085\u20131089. https:\/\/doi.org\/10.1378\/chest.117.4.1085","journal-title":"Chest"},{"issue":"19","key":"362_CR141","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1113\/JP280120","volume":"598","author":"IM Thornell","year":"2020","unstructured":"Thornell IM, Rehman T, Pezzulo AA, Welsh MJ (2020) Paracellular bicarbonate flux across human cystic fibrosis airway epithelia tempers changes in airway surface liquid pH. J Physiol 598(19):4307\u20134320. https:\/\/doi.org\/10.1113\/JP280120","journal-title":"J Physiol"},{"issue":"6","key":"362_CR142","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1164\/rccm.201206-1150OC","volume":"187","author":"K Tiringer","year":"2013","unstructured":"Tiringer K, Treis A, Fucik P, Gona M, Gruber S, Renner S, Dehlink E, Nachbaur E, Horak F, Jaksch P, D\u00f6ring G, Crameri R, Jung A, Rochat MK, H\u00f6rmann M, Spittler A, Klepetko W, Akdis CA, Sz\u00e9pfalusi Z, Frischer T, Eiwegger T (2013) A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 187(6):621\u2013629. https:\/\/doi.org\/10.1164\/rccm.201206-1150OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"362_CR143","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1073\/pnas.0712386105","volume":"105","author":"R Tirouvanziam","year":"2008","unstructured":"Tirouvanziam R, Gernez Y, Conrad CK, Moss RB, Schrijver I, Dunn CE, Davies ZA, Herzenberg LA, Herzenberg LA (2008) Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc Natl Acad Sci USA 105(11):4335\u20134339. https:\/\/doi.org\/10.1073\/pnas.0712386105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"362_CR144","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1016\/j.bbadis.2017.08.011","volume":"1863","author":"L Totani","year":"2017","unstructured":"Totani L, Plebani R, Piccoli A, Di Silvestre S, Lanuti P, Recchiuti A, Cianci E, Dell\u2019Elba G, Sacchetti S, Patruno S, Guarnieri S, Mariggio MA, Mari VC, Anile M, Venuta F, Del Porto P, Moretti P, Prioletta M, Mucilli F, Marchisio M, Pandolfi A, Evangelista V, Romano M (2017) Mechanisms of endothelial cell dysfunction in cystic fibrosis. Biochim Biophys Acta 1863(12):3243\u20133253. https:\/\/doi.org\/10.1016\/j.bbadis.2017.08.011","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"362_CR145","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1183\/09031936.00221711","volume":"40","author":"NTN Trinh","year":"2012","unstructured":"Trinh NTN, Bardou O, Priv\u00e9 A, Maill\u00e9 E, Adam D, Ling\u00e9e S, Ferraro P, Desrosiers M-Y, Coraux C, Brochiero E (2012) Improvement of defective cystic fibrosis airway epithelial wound repair after CFTR rescue. Eur Respir J 40(6):1390\u20131400. https:\/\/doi.org\/10.1183\/09031936.00221711","journal-title":"Eur Respir J"},{"issue":"7","key":"362_CR146","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00230-25","volume":"93","author":"M Vaillancourt","year":"2025","unstructured":"Vaillancourt M, Fernandes SE, Aguilar D, Milesi Galdino AC, Jorth P (2025) A chronic Pseudomonas aeruginosa mouse lung infection modeling the mucus obstruction, lung function, and inflammation of human cystic fibrosis. Infect Immun 93(7):e0023025. https:\/\/doi.org\/10.1128\/iai.00230-25","journal-title":"Infect Immun"},{"issue":"5","key":"362_CR147","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1172\/JCI0213572","volume":"109","author":"RW Vandivier","year":"2002","unstructured":"Vandivier RW, Fadok VA, Hoffmann PR, Bratton DL, Penvari C, Brown KK, Brain JD, Accurso FJ, Henson PM (2002) Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest 109(5):661\u2013670. https:\/\/doi.org\/10.1172\/JCI0213572","journal-title":"J Clin Invest"},{"issue":"3","key":"362_CR148","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.bbrc.2007.02.166","volume":"356","author":"C Verhaeghe","year":"2007","unstructured":"Verhaeghe C, Tabruyn SP, Oury C, Bours V, Griffioen AW (2007) Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells. Biochem Biophys Res Commun 356(3):745\u2013749. https:\/\/doi.org\/10.1016\/j.bbrc.2007.02.166","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"362_CR149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037746","volume":"7","author":"V Verri\u00e8re","year":"2012","unstructured":"Verri\u00e8re V, Higgins G, Al-Alawi M, Costello RW, McNally P, Chiron R, Harvey BJ, Urbach V (2012) Lipoxin A4 stimulates calcium-activated chloride currents and increases airway surface liquid height in normal and cystic fibrosis airway epithelia. PLoS One 7(5):e37746. https:\/\/doi.org\/10.1371\/journal.pone.0037746","journal-title":"PLoS One"},{"key":"362_CR150","doi-asserted-by":"publisher","unstructured":"Vizzardi E, Sciatti E, Bonadei I, Cani DS, Menotti E, Prati F, Dallapellegrina L, Metra M, Berlendis M, Poli P, Padoan R (2019) Macro- and microvascular functions in cystic fibrosis adults without cardiovascular risk factors: a case-control study. Monaldi Arch Chest Dis 89(2). https:\/\/doi.org\/10.4081\/monaldi.2019.1035","DOI":"10.4081\/monaldi.2019.1035"},{"issue":"1","key":"362_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02326-4","volume":"10","author":"L Wang","year":"2025","unstructured":"Wang L, Liang Y, Zhao C, Ma P, Zeng S, Ju D, Zhao M, Yu M, Shi Y (2025) Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential. Sig Transduct Target Ther 10(1):345. https:\/\/doi.org\/10.1038\/s41392-025-02326-4","journal-title":"Sig Transduct Target Ther"},{"issue":"8","key":"362_CR152","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/thx.2004.038240","volume":"60","author":"AP Watt","year":"2005","unstructured":"Watt AP (2005) Neutrophil cell death, activation and bacterial infection in cystic fibrosis. Thorax 60(8):659\u2013664. https:\/\/doi.org\/10.1136\/thx.2004.038240","journal-title":"Thorax"},{"key":"362_CR153","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1242381","volume":"14","author":"D Wellems","year":"2023","unstructured":"Wellems D, Hu Y, Jennings S, Wang G (2023) Loss of CFTR function in macrophages alters the cell transcriptional program and delays lung resolution of inflammation. Front Immunol 14:1242381. https:\/\/doi.org\/10.3389\/fimmu.2023.1242381","journal-title":"Front Immunol"},{"issue":"4","key":"362_CR154","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jcf.2025.03.015","volume":"24","author":"NE West","year":"2025","unstructured":"West NE, Konstan MW, Flume PA, VanDevanter DR, Magaret A, Mazurek H, Amelina EL, Laki I, Chiron R, Sutharsan S, Columbo C, Dorkin HL, Downey DG, Sole A, Hjelte L, Tullis E, Dgetluck N, Dinh Q, Constantine S, White B, Elborn JS, Chmiel JF (2025) Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis. J Cyst Fibros 24(4):691\u2013697. https:\/\/doi.org\/10.1016\/j.jcf.2025.03.015","journal-title":"J Cyst Fibros"},{"issue":"1","key":"362_CR155","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0034-5687(94)00095-h","volume":"99","author":"JH Widdicombe","year":"1995","unstructured":"Widdicombe JH, Widdicombe JG (1995) Regulation of human airway surface liquid. Respir Physiol 99(1):3\u201312. https:\/\/doi.org\/10.1016\/0034-5687(94)00095-h","journal-title":"Respir Physiol"},{"issue":"6","key":"362_CR156","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/ng.838","volume":"43","author":"FA Wright","year":"2011","unstructured":"Wright FA, Strug LJ, Doshi VK, Commander CW, Blackman SM, Sun L, Berthiaume Y, Cutler D, Cojocaru A, Collaco JM, Corey M, Dorfman R, Goddard K, Green D, Kent JW, Lange EM, Lee S, Li W, Luo J, Mayhew GM, Naughton KM, Pace RG, Par\u00e9 P, Rommens JM, Sandford A, Stonebraker JR, Sun W, Taylor C, Vanscoy LL, Zou F, Blangero J, Zielenski J, O\u2019Neal WK, Drumm ML, Durie PR, Knowles MR, Cutting GR (2011) Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet 43(6):539\u2013546. https:\/\/doi.org\/10.1038\/ng.838","journal-title":"Nat Genet"},{"issue":"6","key":"362_CR157","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3892\/mmr.2013.1728","volume":"8","author":"Z-C Yang","year":"2013","unstructured":"Yang Z-C, Yi M-J, Ran N, Wang C, Fu P, Feng X-Y, Xu L, Qu Z-H (2013) Transforming growth factor-\u03b21 induces bronchial epithelial cells to mesenchymal transition by activating the snail pathway and promotes airway remodeling in asthma. Mol Med Rep 8(6):1663\u20131668. https:\/\/doi.org\/10.3892\/mmr.2013.1728","journal-title":"Mol Med Rep"},{"issue":"9","key":"362_CR158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023637","volume":"6","author":"RL Young","year":"2011","unstructured":"Young RL, Malcolm KC, Kret JE, Caceres SM, Poch KR, Nichols DP, Taylor-Cousar JL, Saavedra MT, Randell SH, Vasil ML, Burns JL, Moskowitz SM, Nick JA (2011) Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR. PLoS ONE 6(9):e23637. https:\/\/doi.org\/10.1371\/journal.pone.0023637","journal-title":"PLoS ONE"},{"issue":"3","key":"362_CR159","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2412717122","volume":"122","author":"DA Younis","year":"2025","unstructured":"Younis DA, Marosvari M, Liu W, Pulikkot S, Cao Z, Zhou B, Vella AT, McArdle S, Hu L, Chen Y, Gan W, Yu J, Bruscia EM, Fan Z (2025) CFTR dictates monocyte adhesion by facilitating integrin clustering but not activation. Proc Natl Acad Sci USA 122(3):e2412717122. https:\/\/doi.org\/10.1073\/pnas.2412717122","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"362_CR160","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.152186","volume":"7","author":"X Zhang","year":"2022","unstructured":"Zhang X, Moore CM, Harmacek LD, Domenico J, Rangaraj VR, Ideozu JE, Knapp JR, Woods KJ, Jump S, Jia S, Prokop JW, Bowler R, Hessner MJ, Gelfand EW, Levy H (2022) CFTR-mediated monocyte\/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons. JCI Insight 7(6):e152186. https:\/\/doi.org\/10.1172\/jci.insight.152186","journal-title":"JCI Insight"},{"issue":"12","key":"362_CR161","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082683","volume":"8","author":"C Zhao","year":"2013","unstructured":"Zhao C, Su EM, Yang X, Gao Z, Li L, Wu H, Jiang Y, Su X (2013) Important role of platelets in modulating endotoxin-induced lung inflammation in CFTR-deficient mice. PLoS One 8(12):e82683. https:\/\/doi.org\/10.1371\/journal.pone.0082683","journal-title":"PLoS One"},{"key":"362_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1039241","volume":"13","author":"D Zheng","year":"2022","unstructured":"Zheng D, Liu J, Piao H, Zhu Z, Wei R, Liu K (2022) ROS-triggered endothelial cell death mechanisms: focus on pyroptosis, parthanatos, and ferroptosis. Front Immunol 13:1039241. https:\/\/doi.org\/10.3389\/fimmu.2022.1039241","journal-title":"Front Immunol"}],"container-title":["Current Topics in Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2026_362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T10:39:05Z","timestamp":1791628745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2026_362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":162,"URL":"https:\/\/doi.org\/10.1007\/82_2026_362","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"11 October 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"This study was supported by grants FFC#11\/22 and FFC#12\/24 from the Italian Cystic Fibrosis Research Foundation, grant MATTOSC24I0 from the Cystic Fibrosis Foundation, and grant MFAG2022 ID 27060 from the Associazione Italiana per la Ricerca sul Cancro (AIRC) to DM; grants FFC#15\/2005, FFC#15\/2007, FFC#17\/2012, FFC#19\/2013, and FFC#23\/2014 from the Italian Cystic Fibrosis Research Foundation to MR; grants FFC#21\/2014, FFC#19\/2016, FFC#19\/2020, FFC#20\/2021, and FFC#13\/2024 from the Italian Cystic Fibrosis Research Foundation, grants RECCHI17I0, RECCHI19I0, and RECCHI20G1 from the Cystic Fibrosis Foundation, and grant PRIN PNRR P2022YEPWY from the Italian Ministry of University and Research to AR; and grant GMSG#1\/2023 from the Italian Cystic Fibrosis Research Foundation to RP.All authors declare that they have no conflict of interest.This chapter is a review of previously published accounts; as such, no animal or human studies were performed.","order":1,"name":"Ethics","label":"Compliance with Ethical Standards","group":{"name":"EthicsHeading","label":"Ethics"}}]}}